Clinical Trials Logo

Clinical Trial Details — Status: Suspended

Administrative data

NCT number NCT00281723
Other study ID # 6-12.2.06-HMO-CTIL
Secondary ID
Status Suspended
Phase Phase 2
First received January 24, 2006
Last updated May 6, 2007
Est. completion date May 2007

Study information

Verified date May 2007
Source Hadassah Medical Organization
Contact n/a
Is FDA regulated No
Health authority Israel: Israeli Health Ministry Pharmaceutical Administration
Study type Interventional

Clinical Trial Summary

Recurrent Aphthous Stomatitis (RAS) of the oral mucosa is a common and painful condition. Despite advances in therapeutic means there is still necessary to find a way to alleviate the local pain and discomfort induced by the mucosal ulceration.

The hypothesis was to study the effectiveness and acceptance of a herbal adhesive tablets in the treatment of RAS.

Participants in the study will be examined for oral lesions, will be instructed how to apply the oral-tablet, and will be interviewed during the follow-up period up to one week after the application.


Recruitment information / eligibility

Status Suspended
Enrollment 50
Est. completion date May 2007
Est. primary completion date
Accepts healthy volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria (in healthy individuals):

- Age above 18 years old.

- Non-pregnant women.

- Healthy or controlled chronic diseases.

- Examination at the Oral Medicine Clinic

Inclusion Criteria (in RAS patients):

- Age above 18 years old.

- Non-pregnant women.

- Clinical diagnosis of RAS.

- Examination at the Oral Medicine Clinic

Exclusion Criteria:

- Oral lesion suspected to be malignant.

- Ulcerative oral lesion other than RAS.

- Another experimental oral intervention within the last 24 hours.

- Pregnant women.

- Allergy to components of the Pro-pe adhesive tablet

Study Design

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Pro-Pe adhesive tablet


Locations

Country Name City State
Israel Hadassah Medical Organization, Jerusalem

Sponsors (2)

Lead Sponsor Collaborator
Hadassah Medical Organization Grant from "Axiomedic. Advanced Medical Solutions", Zurich, Switzerland

Country where clinical trial is conducted

Israel, 

References & Publications (1)

Mizrahi B, Golenser J, Wolnerman JS, Domb AJ. Adhesive tablet effective for treating canker sores in humans. J Pharm Sci. 2004 Dec;93(12):2927-35. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Serial questionnaires within 1 week post treatment to assess patient's perception, patient's pain relief and local adverse events in comparison to his past experience with other local treatments for oral ulcers.

External Links